Leica Biosystems and Bristol-Myers Squibb Enter Into a Development and Commercialization Collaboration for Companion Diagnostic

    Leica Biosystems and Bristol-Myers Squibb Enter Into a Development and
    Commercialization Collaboration for Companion Diagnostics that Support
                              Targeted Therapies

PR Newswire

NUSSLOCH, Germany, August 7, 2014

NUSSLOCH, Germany, August 7, 2014 /PRNewswire/ --

  oLeica Biosystems announces a collaboration with Bristol-Myers Squibb to
    develop companion diagnostic tests in support of targeted therapeutics
  oLeica Biosystems will develop fully automated tissue-based companion
    diagnostic tests to run on the BOND™ automated advanced staining systems

Leica Biosystems, today announced an agreement with Bristol-Myers Squibb
Company (NYSE: BMY) to collaborate on developing companion diagnostics on the
Leica BOND system for use as an aid in selecting patients for treatment with
certain pharmaceuticals developed, or to be developed, by Bristol-Myers
Squibb. Other terms of the agreement were not disclosed.

"We are pleased to be working with Bristol-Myers Squibb, on diagnostics for
cancer and other therapies on the Leica BOND platform," added Matthias Weber,
President of Leica Biosystems, MD. "This partnership is an example of Leica's
continued growth in Companion Diagnostics. In this field the capabilities to
supply high quality In Vitro Diagnostic products are critical requirements.
The ease of use and high staining quality of our BOND systems makes them ideal
platforms on which to deploy these very informative tests."

About Leica Biosystems 

Leica Biosystems is a global leader in workflow solutions and automation,
striving to advance cancer diagnostics to improve patients' lives. Leica
Biosystems provides anatomic pathology laboratories and researchers a
comprehensive product range for each step in the pathology process, from
sample preparation and staining to imaging and reporting. Leica's easy-to-use
and reliable offerings help improve workflow efficiency and diagnostic
confidence. The company is represented in over 100 countries. It has
manufacturing facilities in seven countries, sales and service organizations
in 19 countries, and an international network of dealers. The company is
headquartered in Nussloch, Germany. Further information can be found at
LeicaBiosystems.com.

SOURCE Leica Biosystems

Contact: Media Contact(s): Susana Sancen, Global Senior Manager, Marketing
Communications, Susana.Sancen@LeicaBiosystems.com, +1-847-821-3473
 
Press spacebar to pause and continue. Press esc to stop.